Screener
Xeris Biopharma Holdings, Inc. XERS Net debt / EBITDA
Net debt / EBITDA at other companies
Other financials
Where this comes from
Calculated from Xeris Biopharma Holdings, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Xeris Biopharma Holdings, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001867096-26-000065
FAQ
- What is Xeris Biopharma Holdings, Inc.'s net debt / EBITDA?
- Xeris Biopharma Holdings, Inc. (XERS) reported net debt / EBITDA of 4.4× in Q2 2026.
- What does net debt / EBITDA mean?
- Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.
Ask your AI about Xeris Biopharma Holdings, Inc.'s net debt / ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude